Project description
A simple, non-invasive treatment for a dangerous heart disease is on the way
The heart is a complex 4-chamber hydraulic system comprising pumps and valves. Normally, the tricuspid valve between the right atrium and ventricle opens to allow deoxygenated blood from the atrium into the ventricle. When the right ventricle contracts to pump the blood to the lungs for reoxygenation, the valve closes tightly to prevent blood from flowing backward. When the valve is damaged, the results can be lethal. Although severe tricuspid valve dysfunction is a highly prevalent condition, it has been relatively neglected. No longer the case, CVTVT has developed a device that can be delivered to the site non-invasively, restoring tricuspid valve function. Clinical trials and commercialisation will bring this simple life-saving device to patients.
Fields of science
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2
Coordinator
D01 Y0E7 Dublin
Ireland
See on map